Skip to main content
. 2019 Apr 12;68(14):328–329. doi: 10.15585/mmwr.mm6814a3

TABLE. Characteristics of six persons living with human immunodeficiency virus (HIV) infection and acute hepatitis A virus (HAV) infection who had received partial or complete hepatitis A vaccination — Tennessee, December 1, 2017–September 20, 2018.

Characteristic Patient
A B C D E F
Age (yrs)
29
31
30
38
36
55
Interval from HIV diagnosis to HAV infection
5 yrs
9 yrs
3 mos
4 mos
3 mos
5 yrs
No. of doses monovalent HAV vaccine received
2/2
2/2
1/2



No. of doses combined HAV and hepatitis B vaccine received



2/3
1/3
2/3
HAV vaccination status
Full
Full
Partial
Partial
Partial
Partial
Received postexposure prophylaxis
No
No
Yes
No
No
No
Interval from first HAV vaccine dose to HAV infection
8 yrs
8 yrs
2 mos
2 mos
1 mo
5 mos
Interval from most recent HAV vaccine dose to HAV infection
7 yrs
5 yrs
13 days
6 days
1 mo
3 mos
CD4 count before first HAV vaccine dose*
Vaccinated 3 yrs before HIV diagnosis
358
887
532
862
342
HIV viral load before first HAV vaccine dose
Vaccinated before HIV diagnosis
1,886
154
136
2,554
20
CD4 before HAV infection
N/A
243
779
403
N/A
225
HIV viral load before HAV infection N/A 28,474 20 26 N/A 20

Abbreviation: N/A = not available.

* CD4 count >500 cell/mm3 indicates healthy immune function.

HIV viral load <50 copies/mL indicates viral suppression.